August 16, 2017 8:41 PM ET

Biotechnology

Company Overview of ICOS Corporation

Key Executives for ICOS Corporation

NameBoard RelationshipsTitleAge
David Alan Goodkin No RelationshipsChief Medical Officer and Senior Vice President of Development61
John B. Kliewer No RelationshipsGeneral Counsel, Compliance Officer, Vice President and Secretary47
Michele Yetman No RelationshipsVice President of Human Resources and Corporate Officer52
Clifford J. Stocks 10 RelationshipsVice President of Business Development58
Thomas P. St. John Ph.D.No RelationshipsVice President of Therapeutic Development64

ICOS Corporation Board Members*

NameBoard RelationshipsPrimary CompanyAge
David V. Milligan Ph.D. 20 RelationshipsBay City Capital LLC76
Vaughn D. Bryson 44 RelationshipsNuSirt Sciences, Inc.79
Gary L. Wilcox Ph.D. 93 RelationshipsCocrystal Pharma, Inc.70
James L. Ferguson 56 RelationshipsHamilton College91
Robert W. Pangia 41 RelationshipsHighlands Acquisition Corp.67
View All Board Members

ICOS Corporation Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Compensation Committee Vaughn D. Bryson44 Relationships3 Executives
Nominating Committee Ph.D.David V. Milligan20 Relationships4 Executives
Corporate Governance Committee Ph.D.David V. Milligan20 Relationships4 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
386.7K
Bonus
237.8K
Total Short Term Compensation
480.9K
Total Value of Options
18.6M
Compensation as of Fiscal Year
ICOS Corporation CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Allakos Announces Management Appointments
August 15, 2017 2:01 PM ET
Cavion, Inc. Appoints Spyridon Papapetropoulos as Executive Vice President, Research and Development and Chief Medical Officer
August 15, 2017 12:07 PM ET
Jounce Therapeutics Names Hugh Cole as Chief Business Officer and Head of Corporate Development
August 15, 2017 12:00 PM ET
Neon Therapeutics Appoints as Teresa (Terry) Regan as Vice President of Human Resources
August 15, 2017 11:00 AM ET
Sierra Oncology Inc. Announces Establishment of DDR Advisory Committee
August 15, 2017 11:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ICOS Corporation, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.